Predicting Atrial Fibrillation in Patients with Hypertension: Can We Do It?

  • R. G. Tieleman
  • H. J. G. M. Crijns
Conference paper


Hypertension is a silent disorder, which is usually asymptomatic. However, long-standing hypertension increases the risk of developing cardiovascular complications, such as stroke, renal failure, peripheral atherosclerosis, coronary artery disease, and heart failure [1]. Systolic blood pressure is a stronger predictor of cardiovascular complications than diastolic pressure [2], and systolic hypertension in isolation has an especially high complication rate [3]. The reduction of morbidity and mortality by prevention of these potentially serious cardiovascular complications is the primary aim of treatment for hypertension


Atrial Fibrillation Paroxysmal Atrial Fibrillation Atrial Fibrillation Patient Rhythm Control Left Ventricular Wall Thickness 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Chobanian AV, Bakris GL, Black HR et al (2003) The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and treatment of High Blood Pressure: the JNC 7 Report. JAMA 289:2560–2571PubMedCrossRefGoogle Scholar
  2. 2.
    Kannel WB (2000) Elevated systolic blood pressure as a cardiovascular risk factor. Am J Cardiol 85:251–255PubMedCrossRefGoogle Scholar
  3. 3.
    Staessen JA, Gasowski J, Wang JG et al (2000) Risks of untreated and treated isolated systolic hypertension in the elderly: meta-analysis of outcome trials. Lancet 355:865–872PubMedCrossRefGoogle Scholar
  4. 4.
    Krahn AD, Manfreda J, Tate RB, Mathewson FA, Cuddy TE (1995) The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba Follow-Up Study. Am J Med 98:476–484PubMedCrossRefGoogle Scholar
  5. 5.
    Kannel WB, Wolf PA, Benjamin EJ, Levy D (1998) Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates. Am J Cardiol 82:2N–9NPubMedCrossRefGoogle Scholar
  6. 6.
    Benjamin EJ, Wolf PA, D’Agostino RB, Silbershatz H, Kannel WB, Levy D (1998) Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation 98:946–952PubMedCrossRefGoogle Scholar
  7. 7.
    Burt VL, Whelton P, Roccella EJ et al (1995) Prevalence of hypertension in the US adult population. Results from the Third National Health and Nutrition Examination Survey, 1988-1991. Hypertension 25:305–313PubMedCrossRefGoogle Scholar
  8. 8.
    Furberg CD, Psaty BM, Manolio TA, Gardin JM, Smith VE, Rautaharju PM (1994) Prevalence of atrial fibrillation in elderly subjects (the Cardiovascular Health Study). Am J Cardiol 74:236–241PubMedCrossRefGoogle Scholar
  9. 9.
    Kannel WB, Abbott RD, Savage DD, McNamara PM (1982) Epidemiologic features of chronic atrial fibrillation: the Framingham study. N Engl J Med 306:1018–1022PubMedCrossRefGoogle Scholar
  10. 10.
    Psaty BM, Manolio TA, Kuller LH et al (1997) Incidence of and risk factors for atrial fibrillation in older adults. Circulation 96:2455–2461PubMedCrossRefGoogle Scholar
  11. 11.
    Van Gelder IC, Hagens VE, Bosker HA et al (2002) A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation. N Engl J Med 347:1834–1840PubMedCrossRefGoogle Scholar
  12. 12.
    Wyse DG, Waldo AL, DiMarco JP et al (2002) A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med 347:1825–1833PubMedCrossRefGoogle Scholar
  13. 13.
    Verdecchia P, Reboldi G, Gattobigio R et al (2003) Atrial fibrillation in hypertension: predictors and outcome. Hypertension 41:218–23PubMedCrossRefGoogle Scholar
  14. 14.
    Fuster V, Ryden LE, Asinger RW et al (2001) ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: executive summary. A report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation): developed in collaboration with the North American Society of Pacing and Electrophysiology. J Am Coll Cardiol 38:1231–1266PubMedCrossRefGoogle Scholar
  15. 15.
    Page RL, Tilsch TW, Connolly SJ et al (2003) Asymptomatic or “silent” atrial fibrillation: frequency in untreated patients and patients receiving azimilide. Circulation 107:1141–1145PubMedCrossRefGoogle Scholar
  16. 16.
    Van Gelder IC, Crijns HJ, Tieleman RG et al (1996) Chronic atrial fibrillation. Success of serial cardioversion therapy and safety of oral anticoagulation. Arch Intern Med 156:2585–2592PubMedCrossRefGoogle Scholar
  17. 17.
    Li D, Fareh S, Leung TK, Nattel S (1999) Promotion of atrial fibrillation by heart failure in dogs: atrial remodeling of a different sort. Circulation 100:87–95PubMedCrossRefGoogle Scholar
  18. 18.
    Neven K, Tieleman RG, Cheriex EC, Crijns HJGM (2002) The degree of left ventricular hypertrophy predicts the incidence of atrial fibrillation (abstract). Eur Heart J 23:138Google Scholar
  19. 19.
    Dilaveris PE, Gialafos EJ, Sideris SK et al (1998) Simple electrocardiographic markers for the prediction of paroxysmal idiopathic atrial fibrillation. Am Heart J 135:733–738PubMedCrossRefGoogle Scholar
  20. 20.
    Dilaveris PE, Gialafos EJ, Andrikopoulos GK et al (2000) Clinical and electrocardiographic predictors of recurrent atrial fibrillation. Pacing Clin Electrophysiol 23:352–358PubMedCrossRefGoogle Scholar
  21. 21.
    Fukunami M, Yamada T, Ohmori M et al (1991) Detection of patients at risk of paroxysmal atrial fibrillation during sinus rhythm by P-wave triggered signal-averaged electrogram. Circulation 83:162–169PubMedCrossRefGoogle Scholar
  22. 22.
    Klein M, Evans SJ, Blumberg S, Cataldo L, Bodenheimer MM (1995) Use of P-wave-triggered, P-wave signal-averaged electrocardiogram to predict atrial fibrillation after coronary artery bypass surgery. Am Heart J 129:895–901PubMedCrossRefGoogle Scholar
  23. 23.
    Cecchi F, Montereggi A, Olivotto I et al (1997) Risk for atrial fibrillation in patients with hypertrophic cardiomyopathy assessed by signal averaged P-wave duration. Heart 78:44–49PubMedGoogle Scholar
  24. 24.
    Dilaveris PE, Gialafos EJ, Chrissos D et al (1999) Detection of hypertensive patients at risk for paroxysmal atrial fibrillation during sinus rhythm by computer-assisted P wave analysis. J Hypertens 17:1463–1470PubMedCrossRefGoogle Scholar
  25. 25.
    Dilaveris P, Batchvarov V, Gialafos J, Malik M (1999) Comparison of different methods for manual P wave duration measurement in 12-lead electrocardiograms. Pacing Clin Electrophysiol 22:1532–1538PubMedCrossRefGoogle Scholar
  26. 26.
    Ciaroni S, Cuenoud L, Bloch A (2000) Clinical study to investigate the predictive parameters for the onset of atrial fibrillation in patients with essential hypertension. Am Heart J 139:814–819PubMedCrossRefGoogle Scholar
  27. 27.
    Ozer N, Aytemir K, Atalar E et al (2000) P wave dispersion in hypertensive patients with paroxysmal atrial fibrillation. Pacing Clin Electrophysiol 23:1859–1862PubMedGoogle Scholar

Copyright information

© Springer-Verlag Italia 2004

Authors and Affiliations

  • R. G. Tieleman
    • 1
  • H. J. G. M. Crijns
    • 1
  1. 1.Department of CardiologyUniversity Hospital MaastrichtThe Netherlands

Personalised recommendations